 Ocular Therapeutix, Inc. NASDAQ:OCUL Q3 2022 Earnings Conference Call November 7, 2022 4:30 PM ET Company Participants Donald Notman Chief Financial Officer Antony Mattessich President and Chief Executive Officer Rabia Ozden Chief Medical Officer Peter Kaiser Chief Medical Adviser-Retina Conference Call Participants Joe Catanzaro Piper Sandler Kambiz Yazdi Jefferies Yi Chen H.C. Wainwright Yuan Zhi B. 